Potential for anti‑angiogenic therapy targeting the receptor for advanced glycation end products/VEGF axis in ulcerative colitis (Review)
Molecular Medicine Reports · 09.04.2026 · 33 (6) · 1-14
DOI: 10.3892/mmr.2026.13876 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Medicine Reports, online erschienen am 09.04.2026. Verfasst von Chen Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Medicine, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui 230031, P.R. China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Receptor for Advanced Glycation End Products, Vascular Endothelial Growth Factor A, Angiogenesis Inhibitors. Die Arbeit nennt 260 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Intensive Care Medicine, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui 230031, P.R. China.
- Hospital Infection Management Department, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui 230031, P.R. China.
Zitieren
APA
Xu, C., Li, Y., Hong, Y., Zhou, D., He, K., Wang, L., & Hong, F. (2026). Potential for anti‑angiogenic therapy targeting the receptor for advanced glycation end products/VEGF axis in ulcerative colitis (Review). Molecular Medicine Reports, 33(6), 1-14. https://doi.org/10.3892/mmr.2026.13876
Vancouver
Xu C, Li Y, Hong Y, Zhou D, He K, Wang L, et al. Potential for anti‑angiogenic therapy targeting the receptor for advanced glycation end products/VEGF axis in ulcerative colitis (Review). Molecular Medicine Reports. 2026;33(6):1-14. doi:10.3892/mmr.2026.13876
BibTeX
@article{Xu2026,
author = {Xu, Chen and Li, Yuting and Hong, Yahua and Zhou, Dayong and He, Kun and Wang, Lianghui and Hong, Feng},
title = {Potential for anti‑angiogenic therapy targeting the receptor for advanced glycation end products/VEGF axis in ulcerative colitis (Review)},
journal = {Molecular Medicine Reports},
year = {2026},
volume = {33},
number = {6},
pages = {1--14},
doi = {10.3892/mmr.2026.13876}
}
EUVIMED